IMPACT OF MAINTENANCE THERAPY WITH LOW-DOSE GLUCOCORTICOIDS IN PATIENTS UNDERGOING BIOLOGICAL AND TARGETED SYNTHETIC DMARDS FOR RHEUMATOID ARTHRITIS

被引：0
|
作者：
Giollo, A. [1 ]
Zen, M. [1 ]
Salvato, M. [1 ]
Frizzera, F. [1 ]
Botsios, K. [1 ]
Ramonda, R. [1 ]
Doria, A. [1 ]
机构：
[1] Univ Padua, Rheumatol Unit, Padua, Italy
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
D O I：
10.1136/annrheumdis-2023-eular.456
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0460
引用
收藏
页码：487 / 488
页数：2
相关论文
共 50 条
  • [1] Controversies in rheumatology: maintenance therapy with low-dose glucocorticoids in rheumatoid arthritis
    Buttgereit, Frank
    Kvien, Tore K.
    RHEUMATOLOGY, 2022, 62 (01) : 35 - 41
  • [2] THE IMPACT OF LOW-DOSE DMARDS ON BONE MINERAL DENSITY IN EARLY RHEUMATOID ARTHRITIS
    Rexhepi, S.
    Sahatiu-Meka, V.
    Rexhepi, M.
    Rexhepi, B.
    Mahmutaj, V.
    Rexhepi, G.
    Boshnjaku, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S343 - S344
  • [3] Effects of biological and targeted synthetic DMARDs on bone loss in rheumatoid arthritis
    Orsolini, Giovanni
    Fassio, Angelo
    Rossini, Maurizio
    Adami, Giovanni
    Giollo, Alessandro
    Caimmi, Cristian
    Idolazzi, Luca
    Viapiana, Ombretta
    Gatti, Davide
    PHARMACOLOGICAL RESEARCH, 2019, 147
  • [4] Discontinuation Pattern of Glucocorticoids in Patients with Rheumatoid Arthritis Initiating Biologics or Targeted Synthetic DMARDs in Routine Care
    Castrejon, Isabel
    Otero-Varela, Lucia
    Alvaro-Gracia, Jose Maria
    Calvo Gutierrez, Jerusalem
    Campos-Fernandez, Cristina
    Garcia Dorta, Alicia
    Perez, Ana
    Ruiz Montesino, Dolores
    Sanchez-Alonso, Fernando
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4583 - 4584
  • [5] Risk of Cardiovascular Outcomes with Low-Dose Glucocorticoids in Patients with Rheumatoid Arthritis
    Coburn, Brian
    George, Michael
    Baker, Joshua
    Hsu, Jesse
    Wu, Qufei
    Chen, Lang
    Xie, Fenglong
    Yun, Huifeng
    Curtis, Jeffrey
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4000 - 4003
  • [6] GLUCOCORTICOIDS IN RHEUMATOID-ARTHRITIS, ESPECIALLY LOW-DOSE PREDNISOLONE THERAPY (LDPT)
    DREHER, R
    AKTUELLE RHEUMATOLOGIE, 1993, 18 (01) : 8 - 10
  • [7] PREDICTION OF TREATMENT DISCONTINUATION DUE TO ADVERSE EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS USED BIOLOGICAL DMARDS AND TARGETED SYNTHETIC DMARDS
    Koltsova, E.
    Lukina, G.
    Shmidt, E.
    Lytkina, K.
    Zhilyaev, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1211 - 1211
  • [8] The role of low-dose glucocorticoids for rheumatoid arthritis in the biologic era
    Caporali, R.
    Scire, C. A.
    Todoerti, M.
    Montecucco, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2013, 31 (04) : S9 - S13
  • [9] Comparative effects of biological and targeted synthetic DMARDs on incident chronic kidney disease in patients with rheumatoid arthritis
    Nishimura, Nozomi
    Onishi, Akira
    Yamamoto, Wataru
    Nagai, Koji
    Shiba, Hideyuki
    Okita, Yasutaka
    Son, Yonsu
    Amuro, Hideki
    Okano, Takaichi
    Ueda, Yo
    Hara, Ryota
    Katayama, Masaki
    Yamada, Shinsuke
    Hashimoto, Motomu
    Maeda, Yuichi
    Onizawa, Hideo
    Fujii, Takayuki
    Murata, Koichi
    Murakami, Kosaku
    Tanaka, Masao
    Matsuda, Shuichi
    Morinobu, Akio
    RHEUMATOLOGY, 2024,
  • [10] Risk for Serious Infection With Low-Dose Glucocorticoids in Patients With Rheumatoid Arthritis A Cohort Study
    George, Michael D.
    Baker, Joshua F.
    Winthrop, Kevin
    Hsu, Jesse Y.
    Wu, Qufei
    Chen, Lang
    Xie, Fenglong
    Yun, Huifeng
    Curtis, Jeffrey R.
    ANNALS OF INTERNAL MEDICINE, 2020, 173 (11) : 870 - +
12345